Phase three research shows Moderna vaccine against COVID 90%
Moderna reveals 90% of Covid-19 vaccine lasts 6 months after second injection
Moderna has updated the clinical trial of the Covid-19 vaccine (Phase III) to show that its vaccine is effective against 90% of Covid-19 infection and 95% of severe symptoms.
Although the vaccine's effectiveness was 94.5% lower than what was reported last year, Moderna's vaccine was effective in long-term protection against Covid-19.
The announcement from Moderna followsสล็อตxoวอเลท findings by a team of researchers at Duke University in the United States published in the New England Journal of Medicine: The efficacy of Moderna's vaccine was maintained for 6 months after receiving the second dose of the vaccine, which is similar to that of those reported by the moderna vaccine. Pfizer-BioNTech (Pfizer-BioNTech) uses the same production technology.
This latest information brings Moderna one step closer to a process of approving the US Food and Drug Administration (FDA) for a full vaccine. After the green light, use it as an emergency in the age group 18 years and over last month. Dec. last year
Moderna is currently testing the efficacy of the vaccine in the 6 months-17 years old age group and that of the vaccine booster.